Malignant Neoplasm of Stomach Recruiting Phase 2 Trials for Capecitabine (DB01101)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03448835Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Treatment
NCT02954536Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) CancerTreatment
NCT03161522Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerTreatment
NCT03817411Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ CancerTreatment
NCT03342937KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric CancerTreatment
NCT03472365A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric CancerTreatment
NCT02931890Multicentric Randomised Trial for Resectable Gastric CancerTreatment
NCT01665274Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric CancerTreatment
NCT02250209T- XELOX in HER2-positive Stage III Gastric Cancer After D2 GastrectomyTreatment